ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 72 filers reported holding ITEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,941 | -24.9% | 26,022 | -9.2% | 0.00% | -100.0% |
| Q2 2023 | $379,551 | +7.5% | 28,667 | +10.5% | 0.00% | 0.0% |
| Q1 2023 | $353,003 | -31.5% | 25,937 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $515,436 | +3.7% | 26,392 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $497,000 | -10.8% | 26,108 | -3.4% | 0.00% | 0.0% |
| Q2 2022 | $557,000 | -16.5% | 27,029 | +30.3% | 0.00% | 0.0% |
| Q1 2022 | $667,000 | -37.1% | 20,739 | -9.0% | 0.00% | 0.0% |
| Q4 2021 | $1,061,000 | +260.9% | 22,796 | +109.1% | 0.00% | – |
| Q3 2021 | $294,000 | -58.9% | 10,902 | -60.9% | 0.00% | -100.0% |
| Q2 2021 | $715,000 | -29.7% | 27,870 | -6.4% | 0.00% | 0.0% |
| Q1 2021 | $1,017,000 | +77.5% | 29,767 | +75.7% | 0.00% | 0.0% |
| Q4 2020 | $573,000 | +43.6% | 16,944 | +4.8% | 0.00% | 0.0% |
| Q3 2020 | $399,000 | – | 16,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |